Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, effectiveness, and tolerability of 200
mg of RWJ-333369 given twice daily by mouth compared with placebo in the treatment of
Diabetic Peripheral Neuropathy (DPN).